Blue Note Therapeutics Raises $26.25 Million in Series A Financing
05 Mar, 2021
– Zentrela from Hamilton, Canada completed an $850K seed funding round.
– The round was led by Jornic Ventures.
– The company intends to use the funds to further commercialize its proprietary EEG test for cannabis impairment and create a scientific database of cannabis product effects.
– Led by Israel Gasperin, CEO and founder, Zentrela is a neurotech startup advancing the understanding of the brain effects of recreational cannabis and is creating a scientific database of cannabis product effects.